acquired
Stage
About
Retrosense Therapeutics was a biotechnology company focused on developing therapeutic approaches; it was acquired by Allergan in 2016 for $555M.
Explore Retrosense Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.